Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Pre-Tax Profit Margin 2011-2025 | ZTS

Current and historical pre-tax profit margin for Zoetis (ZTS) from 2011 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Zoetis pre-tax profit margin for the three months ending March 31, 2025 was .
  
Zoetis Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2025-03-31 $9.29B $3.20B 34.42%
2024-12-31 $9.26B $3.13B 33.85%
2024-09-30 $9.15B $3.05B 33.34%
2024-06-30 $8.92B $2.89B 32.46%
2024-03-31 $8.73B $2.99B 34.19%
2023-12-31 $8.54B $2.94B 34.36%
2023-09-30 $8.37B $2.88B 34.38%
2023-06-30 $8.22B $2.83B 34.40%
2023-03-31 $8.09B $2.63B 32.44%
2022-12-31 $8.08B $2.66B 32.87%
2022-09-30 $8.01B $2.57B 32.10%
2022-06-30 $8.00B $2.56B 32.05%
2022-03-31 $7.89B $2.53B 32.04%
2021-12-31 $7.78B $2.49B 32.00%
2021-09-30 $7.62B $2.40B 31.54%
2021-06-30 $7.41B $2.34B 31.57%
2021-03-31 $7.01B $2.19B 31.18%
2020-12-31 $6.68B $2.00B 29.90%
2020-09-30 $6.54B $2.01B 30.77%
2020-06-30 $6.34B $1.94B 30.66%
2020-03-31 $6.34B $1.92B 30.24%
2019-12-31 $6.26B $1.80B 28.77%
2019-09-30 $6.15B $1.78B 28.98%
2019-06-30 $6.05B $1.67B 27.65%
2019-03-31 $5.91B $1.65B 27.97%
2018-12-31 $5.83B $1.69B 29.01%
2018-09-30 $5.72B $1.70B 29.75%
2018-06-30 $5.59B $1.70B 30.37%
2018-03-31 $5.44B $1.61B 29.49%
2017-12-31 $5.31B $1.53B 28.74%
2017-09-30 $5.12B $1.33B 25.88%
2017-06-30 $5.02B $1.25B 24.83%
2017-03-31 $4.96B $1.23B 24.87%
2016-12-31 $4.89B $1.23B 25.12%
2016-09-30 $4.89B $1.07B 21.82%
2016-06-30 $4.86B $1.01B 20.71%
2016-03-31 $4.83B $0.65B 13.41%
2015-12-31 $4.77B $0.55B 11.44%
2015-09-30 $4.81B $0.63B 13.12%
2015-06-30 $4.81B $0.60B 12.40%
2015-03-31 $4.79B $0.82B 17.18%
2014-12-31 $4.79B $0.82B 17.14%
2014-09-30 $4.72B $0.79B 16.76%
2014-06-30 $4.61B $0.74B 16.00%
2014-03-31 $4.57B $0.73B 15.87%
2013-12-31 $4.56B $0.69B 15.13%
2013-09-30 $4.48B $0.64B 14.23%
2013-06-30 $4.40B $0.67B 15.14%
2013-03-31 $4.38B $0.73B 16.69%
2012-12-31 $4.34B $0.71B 16.37%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $66.869B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $98.402B 36.91
Daiichi Sankyo, - (DSNKY) Japan $48.872B 24.86
Takeda Pharmaceutical (TAK) Japan $48.269B 10.68
Sandoz Group AG (SDZNY) Switzerland $19.668B 0.00
Merck (MKKGY) Germany $18.191B 15.05
Summit Therapeutics (SMMT) United States $17.973B 0.00
Shionogi (SGIOY) Japan $14.521B 14.55
United Therapeutics (UTHR) United States $13.307B 11.77
Neurocrine Biosciences (NBIX) United States $11.769B 40.31
IPSEN (IPSEY) France $10.376B 0.00
Orion OYJ (ORINY) Finland $9.160B 24.77
Corcept Therapeutics (CORT) United States $7.502B 60.98
Madrigal Pharmaceuticals (MDGL) United States $6.553B 0.00
Stevanato Group S.p.A (STVN) Italy $6.435B 40.87
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.071B 0.00
Grifols, S.A (GRFS) Spain $4.964B 0.00
Soleno Therapeutics (SLNO) United States $3.679B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.858B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.812B 11.42
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.226B 12.17
BioCryst Pharmaceuticals (BCRX) United States $2.149B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.087B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.670B 0.00
Guardian Pharmacy Services (GRDN) United States $1.627B 0.00
Indivior (INDV) United States $1.613B 6.84
Centessa Pharmaceuticals (CNTA) United Kingdom $1.600B 0.00
Evotec AG (EVO) Germany $1.438B 0.00
ARS Pharmaceuticals (SPRY) United States $1.377B 175.25
Ocular Therapeutix (OCUL) United States $1.143B 0.00
Dyne Therapeutics (DYN) United States $1.139B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.110B 45.11
Enliven Therapeutics (ELVN) United States $0.966B 0.00
Ardelyx (ARDX) United States $0.945B 0.00
Harrow (HROW) United States $0.885B 0.00
Collegium Pharmaceutical (COLL) United States $0.869B 4.61
Avadel Pharmaceuticals (AVDL) Ireland $0.835B 0.00
AleAnna (ANNA) United States $0.762B 0.00
Cronos Group (CRON) Canada $0.713B 0.00
Xeris Biopharma Holdings (XERS) United States $0.672B 0.00
Organogenesis (ORGO) United States $0.660B 0.00
KalVista Pharmaceuticals (KALV) United States $0.621B 0.00
Akebia Therapeutics (AKBA) United States $0.607B 0.00
Xencor (XNCR) United States $0.602B 0.00
Relay Therapeutics (RLAY) United States $0.540B 0.00
USANA Health Sciences (USNA) United States $0.537B 11.53
Regulus Therapeutics (RGLS) United States $0.519B 0.00
Savara (SVRA) United States $0.518B 0.00
Bioventus (BVS) United States $0.508B 12.92
Theravance Biopharma (TBPH) Cayman Islands $0.505B 0.00
CytoDyn (CYDY) United States $0.483B 0.00
Elite Pharmaceuticals (ELTP) United States $0.447B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.414B 0.00
Zevra Therapeutics (ZVRA) United States $0.405B 0.00
Verve Therapeutics (VERV) United States $0.389B 0.00
Altimmune (ALT) United States $0.387B 0.00
Siga Technologies (SIGA) United States $0.376B 6.43
Tourmaline Bio (TRML) United States $0.373B 0.00
Heron Therapeutics (HRTX) United States $0.369B 0.00
Oruka Therapeutics (ORKA) United States $0.348B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.326B 8.82
Aquestive Therapeutics (AQST) United States $0.267B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
Wellgistics Health (WGRX) United States $0.236B 0.00
Nature's Sunshine Products (NATR) United States $0.229B 21.03
ProKidney (PROK) United States $0.202B 0.00
Esperion Therapeutics (ESPR) United States $0.193B 0.00
MediWound (MDWD) Israel $0.192B 0.00
OmniAb (OABI) United States $0.189B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Nanobiotix S.A (NBTX) France $0.160B 0.00
Journey Medical (DERM) United States $0.150B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.150B 46.35
Profound Medical (PROF) Canada $0.149B 0.00
Inhibikase Therapeutics (IKT) United States $0.144B 0.00
4D Molecular Therapeutics (FDMT) United States $0.143B 0.00
Korro Bio (KRRO) United States $0.139B 0.00
Aclaris Therapeutics (ACRS) United States $0.139B 0.00
Larimar Therapeutics (LRMR) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Aldeyra Therapeutics (ALDX) United States $0.126B 0.00
Lyell Immunopharma (LYEL) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.121B 0.00
Nektar Therapeutics (NKTR) United States $0.119B 0.00
Lexeo Therapeutics (LXEO) United States $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.088B 0.00
VAXART, INC (VXRT) United States $0.086B 0.00
Galectin Therapeutics (GALT) United States $0.086B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Champions Oncology (CSBR) United States $0.081B 13.27
Dominari Holdings (DOMH) United States $0.077B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
Cassava Sciences (SAVA) United States $0.073B 0.00
Unicycive Therapeutics (UNCY) United States $0.073B 0.00
Context Therapeutics (CNTX) United States $0.072B 0.00
Nutriband (NTRB) United States $0.067B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 49.00
Vivani Medical (VANI) United States $0.061B 0.00
Inotiv (NOTV) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Karyopharm Therapeutics (KPTI) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Prelude Therapeutics (PRLD) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
NRx Pharmaceuticals (NRXP) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
FibroGen (FGEN) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
BioVie (BIVI) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.60
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.17
Carisma Therapeutics (CARM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00